Evidence map›Paper›PMID 40502157›Full record

ArticlebioRxiv : the preprint server for biology2025

An improved model for prediction of de novo designed proteins with diverse geometries.

Benjamin Orr, Stephanie E Crilly, Deniz Akpinaroglu, Eleanor Zhu, Michael J Keiser, Tanja Kortemme

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Benjamin OrrDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco; San Francisco, CA 94143, USA.ORCID 0009-0002-4135-4676
Stephanie E CrillyDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco; San Francisco, CA 94143, USA.ORCID 0000-0002-8151-290X
Deniz AkpinarogluDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco; San Francisco, CA 94143, USA.ORCID 0000-0002-5482-0720
Eleanor ZhuDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco; San Francisco, CA 94143, USA.
Michael J KeiserDepartment of Pharmaceutical Chemistry, University of California, San Francisco; San Francisco, CA 94143, USA.ORCID 0000-0002-1240-2192
Tanja KortemmeDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco; San Francisco, CA 94143, USA.ORCID 0000-0002-8494-680X

Funding

Equipment Supplement - Computational design of proteins and protein functionsR35GM145236 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KORTEMME, TANJA · 2022 to 2025
$2.4M
NIGMS NIH HHS R35 GM145236
6 · The paper itself

Abstract

Nature uses structural variations on protein folds to fine-tune the geometries of proteins for diverse functions, yet deep learning-based de novo protein design methods generate highly regular, idealized protein fold geometries that fail to capture natural diversity. Here, using physics-based design methods, we generated and experimentally validated a dataset of 5,996 stable, de novo designed proteins with diverse non-ideal geometries. We show that deep learning-based structure prediction methods applied to this set have a systematic bias towards idealized geometries. To address this problem, we present a fine-tuned version of Alphafold2 that is capable of recapitulating geometric diversity and generalizes to a new dataset of thousands of geometrically diverse de novo proteins from 5 fold families unseen in fine-tuning. Our results suggest that current deep learning-based structure prediction methods do not capture some of the physics that underlie the specific conformational preferences of proteins designed de novo and observed in nature. Ultimately, approaches such as ours and further informative datasets should lead to improved models that reflect more of the physical principles of atomic packing and hydrogen bonding interactions and enable improved generalization to more challenging design problems.

Identifiers

PMID40502157
PMCPMC12157515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.